Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:EUOrder |
Illumina ordered to divest Grail in 2024
|
| gptkbp:focus |
early cancer detection
|
| gptkbp:foundedYear |
2016
|
| gptkbp:headquartersLocation |
gptkb:Menlo_Park,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Grail (2024, per EU order)
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:name |
gptkb:Grail
|
| gptkbp:parentCompany |
gptkb:Illumina
|
| gptkbp:product |
Galleri blood test
|
| gptkbp:regulates |
European Commission ordered divestment in 2024
|
| gptkbp:website |
https://grail.com
|
| gptkbp:bfsParent |
gptkb:Ilumina
|
| gptkbp:bfsLayer |
7
|